W R Crom

1.3k total citations
23 papers, 1.0k citations indexed

About

W R Crom is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, W R Crom has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 7 papers in Molecular Biology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in W R Crom's work include Acute Lymphoblastic Leukemia research (13 papers), Cancer therapeutics and mechanisms (6 papers) and Acute Myeloid Leukemia Research (5 papers). W R Crom is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Cancer therapeutics and mechanisms (6 papers) and Acute Myeloid Leukemia Research (5 papers). W R Crom collaborates with scholars based in United States and Belgium. W R Crom's co-authors include William E. Evans, Mary V. Relling, John H. Rodman, Raymond L. Blakley, Victor M. Santana, Diane Fairclough, Clinton F. Stewart, Ching‐Hon Pui, Cristin Kearns and D. Ayers and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Environmental Health Perspectives.

In The Last Decade

W R Crom

23 papers receiving 999 citations

Peers

W R Crom

PHEOH

ONCOL

PPCH

HEMAT

William M. Hryniuk United States

M. L. N. Willoughby United Kingdom

G H Reaman United States

Eleanor Kane United Kingdom

John Lilleyman United Kingdom

Peter Johan Moe Norway

Roberto Rivera‐Luna Mexico

Jean‐Marie Leclerc Canada

MV Relling United States

Caroline A. Hastings United States

William M. Hryniuk United States

W R Crom

331 ×0.8

PHEOH

798 ×2.4

ONCOL

360 ×1.4

195 ×0.8

PPCH

143 ×0.6

HEMAT

Citations per year, relative to W R Crom W R Crom (= 1×) peers William M. Hryniuk

Countries citing papers authored by W R Crom

Since Specialization

Citations

This map shows the geographic impact of W R Crom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W R Crom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W R Crom more than expected).

Fields of papers citing papers by W R Crom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W R Crom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W R Crom. The network helps show where W R Crom may publish in the future.

Co-authorship network of co-authors of W R Crom

This figure shows the co-authorship network connecting the top 25 collaborators of W R Crom. A scholar is included among the top collaborators of W R Crom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W R Crom. W R Crom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Houghton, Peter J., et al.. (1997). Probenecid alters topotecan (TPT) systemic and renal disposition. Clinical Pharmacology & Therapeutics. 61(2). 1 indexed citations

Zamboni, William C., W R Crom, Laura C. Bowman, et al.. (1996). Interpatient variability in oral (PO) absorption of topotecan (TPT) in children with relapsed solid tumors.. Clinical Pharmacology & Therapeutics. 59(2). 198–198. 5 indexed citations

Murry, Daryl J., W R Crom, Wilburn E. Reddick, Ravi Bhargava, & William E. Evans. (1995). Liver volume as a determinant of drug clearance in children and adolescents.. Drug Metabolism and Disposition. 23(10). 1110–1116. 96 indexed citations

Crom, W R. (1994). Pharmacokinetics in the child.. Environmental Health Perspectives. 102(suppl 11). 111–117. 49 indexed citations

Relling, Mary V., Diane Fairclough, D. Ayers, et al.. (1994). Patient characteristics associated with high-risk methotrexate concentrations and toxicity.. Journal of Clinical Oncology. 12(8). 1667–1672. 168 indexed citations

Stewart, Clinton F., Sharyn D. Baker, Richard L. Heideman, et al.. (1994). Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity.. Journal of Clinical Oncology. 12(9). 1946–1954. 87 indexed citations

Crom, W R, Xiaolong Luo, WM Roberts, et al.. (1994). Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia. Blood. 84(4). 1237–1242. 63 indexed citations

Kearns, Christine M., Raymond L. Blakley, Victor M. Santana, & W R Crom. (1994). Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.. PubMed. 54(5). 1235–9. 46 indexed citations

Rodman, John H., Mary V. Relling, Clinton F. Stewart, et al.. (1993). Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children.. PubMed. 20(1). 18–29. 33 indexed citations

10.

Santana, Victor M., J Mirro, Cristin Kearns, et al.. (1992). 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.. Journal of Clinical Oncology. 10(3). 364–370. 120 indexed citations

11.

Hurwitz, Craig A., Robert A. Krance, MJ Schell, et al.. (1992). Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital.. PubMed. 6 Suppl 2. 39–43. 13 indexed citations

12.

Gregory, R E, Ching‐Hon Pui, & W R Crom. (1991). Raised plasma methotrexate concentrations following intrathecal administration in children with renal dysfunction.. PubMed. 5(11). 999–1003. 8 indexed citations

13.

Mirro, Joseph, et al.. (1989). Targeted Plasma Drug Concentration: A New Therapeutic Approach to Relapsed Nonlymphoblastic Leukemia in Children. Hämatologie und Bluttransfusion. 32. 82–87. 2 indexed citations

14.

Christensen, Michael L., Gaston K. Rivera, W R Crom, M L Hancock, & W. Evans. (1988). Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia.. Journal of Clinical Oncology. 6(5). 797–801. 27 indexed citations

15.

Arbuck, Susan G., et al.. (1986). Etoposide pharmacokinetics in patients with normal and abnormal organ function.. Journal of Clinical Oncology. 4(11). 1690–1695. 79 indexed citations

16.

Crom, W R, et al.. (1983). Cisplatin-induced changes in bleomycin elimination.. PubMed. 67(6). 587–9. 13 indexed citations

17.

Stewart, Clinton F., W R Crom, & Paul Bowman. (1982). Influence of serum concentration on renal clearance of methotrexate in children with acute lymphocytic leukemia. Annals of Pharmacotherapy. 16(6). 2 indexed citations

18.

Cb, Pratt, et al.. (1982). Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.. PubMed. 65(11-12). 1021–6. 31 indexed citations

19.

Evans, William E., et al.. (1980). Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.. PubMed. 26(13). 1902–4. 47 indexed citations

20.

Evans, W., et al.. (1980). Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.. Clinical Chemistry. 26(13). 1902–1904. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact